PURPOSE: The CyberKnife uses an online prediction model to improve radiation delivery when treating lung tumors. This study evaluates the prediction model used by the CyberKnife radiation therapy system in terms of treatment margins about the gross tumor volume (GTV). METHODS: From the data log files produced by the CyberKnife synchrony model, the uncertainty in radiation delivery can be calculated. Modeler points indicate the tracked position of the tumor and Predictor points predict the position about 115 ms in the future. The discrepancy between Predictor points and their corresponding Modeler points was analyzed for 100 treatment model data sets from 23 de-identified lung patients. The treatment margins were determined in each anatomic direction to cover an arbitrary volume of the GTV, derived from the Modeler points, when the radiation is targeted at the Predictor points. Each treatment model had about 30 min of motion data, of which about 10 min constituted treatment time; only these 10 min were used in the analysis. The frequencies of margin sizes were analyzed and truncated Gaussian normal functions were fit to each direction's distribution. The standard deviation of each Gaussian distribution was then used to describe the necessary margin expansions in each signed dimension in order to achieve the desired coverage. In this study, 95% modeler point coverage was compared to 99% modeler coverage. Two other error sources were investigated: the correlation error and the targeting error. These were added to the prediction error to give an aggregate error for the CyberKnife during treatment of lung tumors. RESULTS: Considering the magnitude of 2sigma from the mean of the Gaussian in each signed dimension, the margin expansions needed for 95% modeler point coverage were 1.2 mm in the lateral (LAT) direction and 1.7 mm in the anterior-posterior (AP) direction. For the superior-inferior (SI) direction, the fit was poor; but empirically, the expansions were 3.5 mm. For 99% modeler point coverage, the AP margin was 3.6 mm and the lateral margin was 2.9 mm. The SI margins for 99% modeler point coverage were highly variable. The aggregate error at 95% was 6.9 mm in the SI direction, 4.6 mm in the AP direction, and 3.5 in the lateral direction. CONCLUSIONS: The Predictor points follow the Modeler points closely. Margins were found in each clinical direction that would provide 95% modeler point coverage for 95% of the models reviewed in this study. Similar margins were found in two clinical directions for 99% modeler point coverage in 95% of models. These results can offer guidance in the selection of CTV margins for treatment with the CyberKnife.
PURPOSE: The CyberKnife uses an online prediction model to improve radiation delivery when treating lung tumors. This study evaluates the prediction model used by the CyberKnife radiation therapy system in terms of treatment margins about the gross tumor volume (GTV). METHODS: From the data log files produced by the CyberKnife synchrony model, the uncertainty in radiation delivery can be calculated. Modeler points indicate the tracked position of the tumor and Predictor points predict the position about 115 ms in the future. The discrepancy between Predictor points and their corresponding Modeler points was analyzed for 100 treatment model data sets from 23 de-identified lung patients. The treatment margins were determined in each anatomic direction to cover an arbitrary volume of the GTV, derived from the Modeler points, when the radiation is targeted at the Predictor points. Each treatment model had about 30 min of motion data, of which about 10 min constituted treatment time; only these 10 min were used in the analysis. The frequencies of margin sizes were analyzed and truncated Gaussian normal functions were fit to each direction's distribution. The standard deviation of each Gaussian distribution was then used to describe the necessary margin expansions in each signed dimension in order to achieve the desired coverage. In this study, 95% modeler point coverage was compared to 99% modeler coverage. Two other error sources were investigated: the correlation error and the targeting error. These were added to the prediction error to give an aggregate error for the CyberKnife during treatment of lung tumors. RESULTS: Considering the magnitude of 2sigma from the mean of the Gaussian in each signed dimension, the margin expansions needed for 95% modeler point coverage were 1.2 mm in the lateral (LAT) direction and 1.7 mm in the anterior-posterior (AP) direction. For the superior-inferior (SI) direction, the fit was poor; but empirically, the expansions were 3.5 mm. For 99% modeler point coverage, the AP margin was 3.6 mm and the lateral margin was 2.9 mm. The SI margins for 99% modeler point coverage were highly variable. The aggregate error at 95% was 6.9 mm in the SI direction, 4.6 mm in the AP direction, and 3.5 in the lateral direction. CONCLUSIONS: The Predictor points follow the Modeler points closely. Margins were found in each clinical direction that would provide 95% modeler point coverage for 95% of the models reviewed in this study. Similar margins were found in two clinical directions for 99% modeler point coverage in 95% of models. These results can offer guidance in the selection of CTV margins for treatment with the CyberKnife.
Authors: Noëlle C van der Voort van Zyp; Jean-Briac Prévost; Mischa S Hoogeman; John Praag; Bronno van der Holt; Peter C Levendag; Robertus J van Klaveren; Peter Pattynama; Joost J Nuyttens Journal: Radiother Oncol Date: 2009-03-16 Impact factor: 6.280
Authors: Francesco Tuniz; Scott G Soltys; Clara Y Choi; Steven D Chang; Iris C Gibbs; Nancy J Fischbein; John R Adler Journal: Neurosurgery Date: 2009-11 Impact factor: 4.654
Authors: Saloomeh Vahdat; Eric K Oermann; Sean P Collins; Xia Yu; Malak Abedalthagafi; Pedro Debrito; Simeng Suy; Shadi Yousefi; Constanza J Gutierrez; Thomas Chang; Filip Banovac; Eric D Anderson; Giuseppe Esposito; Brian T Collins Journal: J Hematol Oncol Date: 2010-02-04 Impact factor: 17.388
Authors: W T Brown; X Wu; F Fayad; J F Fowler; S García; M I Monterroso; A de la Zerda; J G Schwade Journal: Clin Oncol (R Coll Radiol) Date: 2009-08-13 Impact factor: 4.126
Authors: Brian T Collins; Saloomeh Vahdat; Kelly Erickson; Sean P Collins; Simeng Suy; Xia Yu; Ying Zhang; Deepa Subramaniam; Cristina A Reichner; Ismet Sarikaya; Giuseppe Esposito; Shadi Yousefi; Carlos Jamis-Dow; Filip Banovac; Eric D Anderson Journal: J Hematol Oncol Date: 2009-01-17 Impact factor: 17.388
Authors: Susanne Stera; Panagiotis Balermpas; Mark K H Chan; Stefan Huttenlocher; Stefan Wurster; Christian Keller; Detlef Imhoff; Dirk Rades; Jürgen Dunst; Claus Rödel; Guido Hildebrandt; Oliver Blanck Journal: Strahlenther Onkol Date: 2017-09-05 Impact factor: 3.621
Authors: Guang Li; Jie Wei; Hailiang Huang; Qing Chen; Carl P Gaebler; Tiffany Lin; Amy Yuan; Andreas Rimner; James Mechalakos Journal: Med Phys Date: 2016-03 Impact factor: 4.071
Authors: Lukas Knybel; Jakub Cvek; Radek Neuwirth; Otakar Jiravsky; Jan Hecko; Marek Penhaker; Marek Sramko; Josef Kautzner Journal: Rep Pract Oncol Radiother Date: 2021-02-25